智通财经APP讯，启明医疗-B(02500)发布公告，于2025年3月20日(交易时段后)，本公司与认购人订立认购协议，认购人已有条件同意认购，而本公司已有条件同意，按每股转换股份初步转换价4.50港元发行本金总额不超过人民币2亿元的可转换债券。
假设所有转换股份按初步转换价每股转换股份4.50港元悉数获转换，则本公司将发行合共4812.45万股转换股份，相当于截至本公告日期本公司全部已发行股本的约10.91%;及经发行转换股份扩大的本公司全部已发行股本的约9.84%。
债券的所得款项净额(经扣除相关开支及专业费用)预计约为人民币1.99亿元，根据初步转换价，相当于每股转换股份净发行价约4.48港元。本集团拟将发行债券的所得款项净额主要用于加快其核心产品管线的开发;改善本集团的资本架构;及补充一般企业营运资金需求。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.